[HTML][HTML] PD1 signal transduction pathways in T cells
H Arasanz, M Gato-Cañas, M Zuazo, M Ibañez-Vea… - Oncotarget, 2017 - ncbi.nlm.nih.gov
The use of immune checkpoint inhibitors for the treatment of cancer is revolutionizing
oncology. Amongst these therapeutic agents, antibodies that block PD-L1/PD1 interactions …
oncology. Amongst these therapeutic agents, antibodies that block PD-L1/PD1 interactions …
Tumour immunogenicity, antigen presentation, and immunological barriers in cancer immunotherapy
D Escors - New journal of science, 2014 - Wiley Online Library
Since the beginning of the 20th century, scientists have tried to stimulate the antitumour
activities of the immune system to fight against cancer. However, the scientific effort devoted …
activities of the immune system to fight against cancer. However, the scientific effort devoted …
Immune modulation by genetic modification of dendritic cells with lentiviral vectors
Our work over the past eight years has focused on the use of HIV-1 lentiviral vectors
(lentivectors) for the genetic modification of dendritic cells (DCs) to control their functions in …
(lentivectors) for the genetic modification of dendritic cells (DCs) to control their functions in …
Future Perspectives
The participation of myeloid cells in tumor progression and metastasis has been known for a
long time. The role of M2 macrophages, tolerogenic DCs, and N2 neutrophils in tumor …
long time. The role of M2 macrophages, tolerogenic DCs, and N2 neutrophils in tumor …
[引用][C] PD1 signal transduction pathways in T cells
H Arasanz Esteban, M Gato Cañas… - Oncotarget, 2017, 8 …, 2017 - Impact Journals